Literature DB >> 11108960

The annexinopathies: a new category of diseases.

J H Rand1.   

Abstract

The annexins are a family of highly homologous phospholipid binding proteins, which share a four-domain structure, with one member of the family - annexin VI - having a duplication consisting of eight domains. Thus far, ten annexins have been described in mammals. Although the biological functions of the annexins have not been definitively established, two human diseases involving annexin abnormalities ('annexinopathies') have been identified as of the time of writing. Overexpression of annexin II occurs in the leukocytes of a subset of patients having a hemorrhagic form of acute promyelocytic leukemia. Underexpression of annexin V occurs on placental trophoblasts in the antiphospholipid syndrome and in preeclampsia. Also, an animal model has been described in which annexin VII is underexpressed and is associated with disease, but the relevance of this animal model to human disease is not yet understood. Future research is likely to elucidate additional 'annexinopathies'.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108960     DOI: 10.1016/s0167-4889(00)00093-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  Hydrophobic protein in colorectal cancer in relation to tumor stages and grades.

Authors:  Lay-Chin Yeoh; Chee-Keat Loh; Boon-Hui Gooi; Manjit Singh; Lay-Harn Gam
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

Review 2.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

3.  Amarcord: I remember.

Authors:  Ernesto Carafoli
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

4.  ANXA5: a key to unlock the mystery of the spectrum of placental-mediated pregnancy complications?

Authors:  Laura Ormesher; Ian A Greer
Journal:  Womens Health (Lond)       Date:  2016-02-22

5.  Obstetric complication-associated ANXA5 promoter polymorphisms may affect gene expression via DNA secondary structures.

Authors:  Hidehito Inagaki; Sayuri Ota; Haruki Nishizawa; Hironori Miyamura; Kumiko Nakahira; Machiko Suzuki; Sachie Nishiyama; Takema Kato; Itaru Yanagihara; Hiroki Kurahashi
Journal:  J Hum Genet       Date:  2019-02-22       Impact factor: 3.172

Review 6.  Annexin A2 system in human biology: cell surface and beyond.

Authors:  Min Luo; Katherine A Hajjar
Journal:  Semin Thromb Hemost       Date:  2013-03-12       Impact factor: 4.180

7.  Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells.

Authors:  Claire Hastie; John R Masters; Stephen E Moss; Soren Naaby-Hansen
Journal:  J Biol Chem       Date:  2008-01-22       Impact factor: 5.157

8.  Salivary proteomic analysis of diabetic patients for possible oral squamous cell carcinoma biomarkers.

Authors:  Veronika A Jancsik; Gabor Gelencser; Gabor Maasz; Janos Schmidt; Gergo A Molnar; Istvan Wittmann; Lajos Olasz; Laszlo Mark
Journal:  Pathol Oncol Res       Date:  2013-12-17       Impact factor: 3.201

9.  Proteomics-based analysis of invasion-related proteins in malignant gliomas.

Authors:  Tomoko Maruo; Tomotsugu Ichikawa; Hirotaka Kanzaki; Satoshi Inoue; Kazuhiko Kurozumi; Manabu Onishi; Koichi Yoshida; Hirokazu Kambara; Mamoru Ouchida; Kenji Shimizu; Seiji Tamaru; E Antonio Chiocca; Isao Date
Journal:  Neuropathology       Date:  2012-11-01       Impact factor: 1.906

10.  Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status.

Authors:  Juana Maria Garcia Pedrero; M Pilar Fernandez; Reginald O Morgan; Agustin Herrero Zapatero; Maria Victoria Gonzalez; Carlos Suarez Nieto; Juan Pablo Rodrigo
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.